cafdapostpartum08082.jpg
A pregnant woman lays in a hospital bed. The FDA approved Zurzuvae, the first pill to treat postpartum depression, Aug. 4, 2023.
A pregnant woman lays in a hospital bed. The FDA approved Zurzuvae, the first pill to treat postpartum depression, Aug. 4, 2023.